ArticleGels (Basel, Switzerland)2026
Effect of Plasma Gel on Viability, Proliferation and Migration of Dermal Human Fibroblasts In Vitro.
Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
This study evaluated plasma gel preparation protocols with potential to yield more biocompatible materials for facial aesthetic applications. Human dermal fibroblasts were cultured in medium supplemented with 20% plasma gel obtained using four protocols: G1, centrifugation at 580 g for 8 min in tubes with anticoagulant followed by activation with 10% calcium chloride; G2, centrifugation at 580 g for 8 min in tubes with anticoagulant without activation; G3, centrifugation at 210 g for 8 min in tubes without anticoagulant with activation; and G4, centrifugation at 210 g for 8 min in tubes without anticoagulant and without activation. All protocols involved heating plasma at 76 °C for 12 min to produce gels. Cell viability was assessed using MTT and Crystal Violet assays over 72 h. Cell morphology and fibrin formation were analyzed by hematoxylin/eosin staining. Cell migration was evaluated using a wound healing assay. RT-qPCR analysis of COL1A1 and FN1 was performed after 24, 48, and 72 h. Fibroblasts cultured with plasma gel from G3 and G4 showed significantly higher viability compared with the control group. G1 and G2 exhibited increased fibrin formation and reduced cell density. Slower wound closure was observed in G2, which was consistent with increased late-stage expression of COL1A1 and FN1. In the conditions evaluated, low-speed centrifugation and the use of tubes without anticoagulant improved plasma gel biocompatibility. Lack of activation after high-speed centrifugation was associated with slower wound closure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.